IP Library › Granted Patent US 11,200,298
Granted Patent B2
US 11,200,298 · App. 16/070,224 · Granted Dec 14, 2021

Reducing probability of glass breakage in drug delivery devices

Inventors: Sean Fitzgibbon (Camarillo, CA); Christopher R. Folk (San Diego, CA); Julian Jazayeri (Woodland Hills, CA)
Assignee: AMGEN INC.
G06F17/18A61M5/2033A61M5/315G06F30/17G06F30/20G16H20/17A61M5/3202A61M2005/206A61M2205/3327A61M2205/3331A61M2205/3375A61M2205/50A61M2205/70A61M2207/00G06F17/13G06F2111/08G06F2111/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,200,298
App. No.
16/070,224
Granted
Dec 14, 2021
Kind
B2
Abstract

A method for determining predicted failure rates of drug injection devices includes receiving a set of parameters that specify physical properties of (i) a syringe, and (ii) a liquid drug, and (iii) a drug injection device configured to deliver the liquid drug to a patient via the syringe. The method further includes receiving failure rate data that specifies a measured rate of failure of the drug injection device in response to various peak pressures within the syringe, applying the received set of parameters to a kinematic model of the drug injection device to determine a predicted peak pressure within the syringe, including determining the predicted peak pressure as a function of impact velocity of the liquid drug, determining a probability of failure of the drug injection device using (i) the received failure rate data and (ii) the predicted peak pressure, and providing an indication of the determined probability of failure to an output device.

Claims (49)

1. A non-transitory computer-readable medium storing thereon instructions that, when executed on one or more processors, implement a method for determining predicted failure rates of drug injection devices, the method comprising:

receiving a set of parameters that specify physical properties of (i) a syringe, and (ii) a liquid drug, and (iii) a drug injection device configured to deliver the liquid drug to a patient via the syringe, wherein the drug injection device includes a mechanism configured to drive a plunger rod toward a plunger of the syringe encased in a syringe carrier;

receiving failure rate data that specifies a measured rate of failure of the drug injection device in response to various peak pressures within the syringe;

applying the received set of parameters to a one-dimensional (1D) kinematic model of the drug injection device to determine a predicted peak pressure within the syringe, including determining the predicted peak pressure as a function of impact velocity of the liquid drug, and including using the 1D kinematic model to model interactions between at least the mechanism, the plunger rod, the plunger, and the syringe carrier, wherein using the 1D kinematic model includes (A) modeling the mechanism as a linear spring with an equilibrium length, and/or (B) modeling (i) a pre-impact stage at which the plunger rod has not come in contact with the plunger, and (ii) a first impact stage at which the plunger rod comes in contact with the plunger;

determining a probability of failure of the drug injection device using (i) the received failure rate data and (ii) the predicted peak pressure; and

providing an indication of the determined probability of failure to an output device.

2. The computer-readable medium of claim 1 , wherein the implemented method further comprises modeling a fluid column in the syringe as an acoustic medium.

3. The computer-readable medium of claim 1 , wherein the implemented method further comprises modeling a fluid column in the syringe using a Korteweg equation.

4. The computer-readable medium of claim 1 , wherein using the 1D kinematic model includes modeling (i) the pre-impact stage at which the plunger rod has not come in contact with the plunger, (ii) the first impact stage at which the plunger rod comes in contact with the plunger, and (iii) a third impact stage at which the syringe carrier comes in contact with a front shell.

5. The computer-readable medium of claim 1 , wherein receiving the set of parameters to the 1D kinematic model includes receiving geometric parameters related to at least one of the syringe or the drug injection device, including at least one of: (i) plunger depth, (ii) plunger rod wall thickness, (iii) plunger rod activation length, (iv) syringe barrel diameter, (v) syringe wall thickness, (vi) fluid volume, (vii) syringe carrier activation length, (viii) plunger rod depth, (ix) length of the guide rod, (x) length of guide rod base, (xi) length of needle insertion, (xii) needle length, (xiii) needle, or (xiv) un-sprung length of spring.

6. The computer-readable medium of claim 1 , wherein receiving the set of parameters to the 1D kinematic model includes receiving parameters indicative of masses of components, including at least one of: (i) mass of syringe carrier, (ii) mass of pre-filled syringe with drug, (iii) mass of plunger, (iv) mass of rod, or (iv) mass of spring.

7. The computer-readable medium of claim 1 , wherein receiving the set of parameters to the 1D kinematic model includes receiving at least one of the following (a) through (e):

(a) a parameter indicative of plunger elasticity,

(b) a parameter indicative of fluid sound speed,

(c) a parameter indicative of viscosity of the drug,

(d) a spring constant, and/or

(e) experimental data indicative of a plurality of test runs of an actual drug injector device that shares at several physical properties with the drug injection device being modeled, and deriving one or more of (i) syringe driver friction, (ii) internal plunger damping, and (iii) plunger-syringe friction.

8. The computer-readable medium of claim 1 , wherein determining the probability of failure of the drug injection device includes applying a two-term Weibull distribution function.

9. A method for manufacturing drug injection devices, the method comprising:

receiving, by one or more processors, a fixed set of parameters that specify physical properties of a syringe and a liquid drug;

determining a set of parameters that specify physical properties of a drug injection device configured to deliver the liquid drug to a patient via the syringe, wherein the drug injection device includes a mechanism configured to drive a plunger rod toward a plunger of the syringe encased in a syringe carrier, wherein determining the set of parameters includes:

(i) generating, by the one or more processors, a candidate set of parameters for the drug injection device,

(ii) applying, by the one or more processors, the fixed set of parameters and the candidate set of parameters to a one-dimensional (1D) kinematic model of the drug injection device to determine a predicted peak pressure within the syringe, including determining the predicted peak pressure as a function of impact velocity of the liquid drug, and including using the 1D kinematic model to model interactions between at least the mechanism, the plunger rod, the plunger, and the syringe carrier, wherein using the 1D kinematic model includes (A) modeling the mechanism as a linear spring with an equilibrium length, and/or (B) modeling (i) a pre-impact stage at which the plunger rod has not come in contact with the plunger, and (ii) a first impact stage at which the plunger rod comes in contact with the plunger,

(iii) determining, by the one or more processors, a probability of failure of the drug injection device using the determined predicted peak pressure,

(iv) if the probability of failure is above a threshold value, repeating the steps (i)-(iii) with a modified candidate set of parameters, and

(v) selecting the candidate set of parameters if the probability of failure is not above the threshold value; and

manufacturing the drug injection device using the determined set of parameters.

10. The method of claim 9 , further comprising modeling a fluid column in the syringe as an acoustic media.

11. The method of claim 9 , further comprising modeling a fluid column in the syringe using a Korteweg equation.

12. The method of claim 9 , wherein using the 1D kinematic model includes modeling (i) the pre-impact stage at which the plunger rod has not come in contact with the plunger, (ii) the first impact stage at which the plunger rod comes in contact with the plunger, and (iii) a third impact stage at which the syringe carrier comes in contact with a front shell.

13. The method of claim 9 , wherein receiving the set of parameters that specify the physical properties of the drug injection device includes receiving at least one of the following (a) through (g):

(a) geometric parameters for one or several components of the drug injection device,

(b) parameters indicative of masses of components of the drug injection device

(c) a parameter indicative of plunger elasticity,

(d) a parameter indicative of fluid sound speed,

(e) a parameter indicative of viscosity of the drug,

(f) a spring constant, and/or

(g) experimental data indicative of a plurality of test runs of an actual drug injector device that shares at several physical properties with the drug injection device being modeled, and deriving one or more of (i) syringe driver friction, (ii) internal plunger damping, and (iii) plunger-syringe friction.

14. A drug injection device configured to deliver a liquid drug to a patient via a syringe, the drug injection device prepared by a process comprising:

receiving a fixed set of parameters that specify physical properties of a syringe and a liquid drug;

determining a set of parameters that specify physical properties of a drug injection device configured to deliver the liquid drug to a patient via the syringe, wherein the drug injection device includes a mechanism configured to drive a plunger rod toward a plunger of the syringe encased in a syringe carrier, and wherein determining the set of parameters includes:

(i) generating a candidate set of parameters for the drug injection device;

(ii) applying the fixed set of parameters and the candidate set of parameters to a one-dimensional (1D) kinematic model of the drug injection device to determine a predicted peak pressure within the syringe, including determining the predicted peak pressure as a function of impact velocity of the liquid drug, and including using the 1D kinematic model to model interactions between at least the mechanism, the plunger rod, the plunger, and the syringe carrier, wherein using the 1D kinematic model includes (A) modeling the mechanism as a linear spring with an equilibrium length, and/or (B) modeling (i) a pre-impact stage at which the plunger rod has not come in contact with the plunger, and (ii) a first impact stage at which the plunger rod comes in contact with the plunger,

(iii) determining a probability of failure of the drug injection device using the determined predicted peak pressure,

(iv) if the probability of failure is above a threshold value, repeating the steps (i)(iii) with a modified candidate set of parameters, and

(v) selecting the candidate set of parameters if the probability of failure is not above the threshold value; and

using the determined set of parameters to manufacture the drug injection device.

15. The drug injection device of claim 14 , wherein the process further comprises modeling a fluid column in the syringe as an acoustic media.

16. The drug injection device of claim 14 , wherein the process further comprises modeling a fluid column in the syringe using a Korteweg equation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2019
From: FITZGIBBON, SEAN; FOLK, CHRISTOPHER R.; JAZAYERI, JULIAN
To: AMGEN INC
Reel/Frame 048460/0418 →
Continuity (2)
Provisional Application 62308578 · Mar 15, 2016
Related Publication 20190050375A1 · Feb 14, 2019
Cited By (2)
US 12,216,736 US 12,350,469